N-̼ʻ-N'-(ױ-2-)-L- Ӣ Fmoc-Arg(Mts)-OH CAS̖ 88743-97-9 578.67900 ܶ 1.35g/cm3 c N/A ʽ C30H34N4O6S
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0104693 | 100mg |
1
|
ԃr |
Q-0104693 | 250mg |
1
|
ԃr |
Q-0104693 | 500mg |
1
|
ԃr |
Q-0104693 | 1g |
1
|
ԃr |
Q-0104693 | 5g |
1
|
ԃr |
N-Fmoc-N’-(ױ-2-)-L-
Ӣ (2S)-5-[[amino-[(2,4,6-trimethylphenyl)sulfonylamino]methylidene]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid
Ąe Nα-Fmoc-Nω-(ױ-2-)-L- | N-FMOC-N'-(ױ-2-)-L- | N-̼ʻ-N'-(ױ-2-)-L-
W|
ܶ 1.35g/cm3
ʽ C30H34N4O6S
578.67900
| 578.22000
PSA 166.06000
LogP 6.53980
1.644
PaƷ
FMOC-O-BUTYL-L-TYROSINE N-HYDROXYSUCCINIMIDE ESTER
S--L-װ嶡}}
H-Tyr(Tos)-OH
N-ACETYL-S-METHYL-L-CYSTEINE
FMOC-[FMOC-HMB]-LYS(BOC)-OH
(2S,3R)-2-(((S)ʻ))-3-(嶡)
N-[2-(һ)һ]ʮ
;
aأ
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|ָˣ | 95%+ |
ܽl | ЙC܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
aSң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
N--DL- Ӣ ac-dl-phe-oh CAS̖ 2901-61-3 207.22600 ܶ N/A c N/A ʽ C11H13NO3
-
Ӣ 1-(benzofuran-7-yl)-N-methylmethanamine ʽ C10H11NO 161.20000 | 161.08400 PSA 25.17000 LogP 2.54310